Zhende Medical Co Ltd (603301) — Capital Reinvestment Ratio
Zhende Medical Co Ltd (603301) has a Capital Reinvestment Ratio of 1.07x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥101.93 Million) in capital expenditures (CN¥109.24 Million). Check 603301 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhende Medical Co Ltd Capital Reinvestment Ratio (2014–2025)
This chart tracks Zhende Medical Co Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see 603301 cash flow metrics.
Annual Capital Reinvestment Ratio for Zhende Medical Co Ltd (2014–2025)
Year-by-year Capital Reinvestment Ratio for Zhende Medical Co Ltd from 2014 to 2025. See 603301 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.02x | CN¥538.49 Million | CN¥550.22 Million | ▼ -38.8% |
| 2024 | 1.67x | CN¥461.14 Million | CN¥769.69 Million | ▲ +25.9% |
| 2023 | 1.33x | CN¥452.11 Million | CN¥599.24 Million | ▲ +119.0% |
| 2022 | 0.61x | CN¥1.25 Billion | CN¥754.12 Million | ▼ -28.8% |
| 2021 | 0.85x | CN¥817.63 Million | CN¥695.47 Million | ▲ +142.9% |
| 2020 | 0.35x | CN¥3.12 Billion | CN¥1.09 Billion | ▼ -74.7% |
| 2019 | 1.38x | CN¥197.76 Million | CN¥273.79 Million | ▼ -87.6% |
| 2018 | 11.20x | CN¥20.25 Million | CN¥226.70 Million | ▲ +1313.5% |
| 2017 | 0.79x | CN¥182.34 Million | CN¥144.45 Million | ▼ -31.1% |
| 2016 | 1.15x | CN¥138.57 Million | CN¥159.23 Million | ▲ +608.9% |
| 2015 | 0.16x | CN¥142.70 Million | CN¥23.13 Million | ▼ -76.6% |
| 2014 | 0.69x | CN¥83.63 Million | CN¥57.93 Million | — |